Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$314K Buy
2,945
+654
+29% +$79.2K 0.01% 1264
2026
Q1
$375K Sell
2,291
-31
-1% -$4.77K 0.01% 1088
2025
Q4
$404K Sell
2,322
-82
-3% -$15K 0.01% 1022
2025
Q3
$346K Sell
2,404
-19
-0.8% -$2.33K 0.01% 1017
2025
Q2
$244K Buy
2,423
+552
+30% +$42.2K 0.01% 1175
2025
Q1
$143K Sell
1,871
-23
-1% -$1.76K ﹤0.01% 1334
2024
Q4
$131K Buy
1,894
+54
+3% +$3.89K ﹤0.01% 1334
2024
Q3
$134K Buy
1,840
+19
+1% +$1.4K ﹤0.01% 1280
2024
Q2
$122K Buy
+1,821
New +$70.6K ﹤0.01% 1279

Other funds holding INSM

IFP Advisors's INSM Position: Q2 2026 in Review

IFP Advisors increased its Insmed (INSM) stake by 29% in Q2 2026, buying an estimated $79.2K and bringing the position to 2,945 shares worth $314K. The position accounts for 0.01% of the portfolio, ranked #1264.

IFP Advisors first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $404K in Q4 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • IFP Advisors held 2,945 shares of Insmed worth $314K as of Q2 2026.
  • IFP Advisors bought 654 Insmed shares in Q2 2026, an estimated $79.2K.
  • Insmed made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #1264 holding.
  • IFP Advisors first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • IFP Advisors's Insmed position peaked at $404K in Q4 2025.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.